NCI Cancer Center News
Dialing back treg cell function boosts the body's cancer-fighting immune activity
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses. The new research, performed in animals by scientists from Children's Hospital of Philadelphia and the University of Pennsylvania (home of the Abramson Cancer Center), is not ready for clinical use in humans. However, the approach, making use of a key protein to control immune function, lends itself to further study using candidate drugs that employ the same mechanisms.Click here to read full press release
###
No hay comentarios:
Publicar un comentario